AC Immune SALong
ACIU - long - upcoming catalysts - RISKY!
Updated
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
This is not a financial advice!
This could be a sleeping giant but its very speculative - keep in mind!
1 upcoming catalyst on 6th of March 2024 and on 31st of March another one end of June
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
The volume is still a bit low - want to see an increase.
Needs to break 3.5 resistance before entry
Keep an eye on 4.20, 4.60 and 5.20 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 3.0
TP approx. 6.0 (even 12.0 possible)
Most info on the chart.
Trade carefully!
This is not a financial advice!
This could be a sleeping giant but its very speculative - keep in mind!
1 upcoming catalyst on 6th of March 2024 and on 31st of March another one end of June
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
The volume is still a bit low - want to see an increase.
Needs to break 3.5 resistance before entry
Keep an eye on 4.20, 4.60 and 5.20 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 3.0
TP approx. 6.0 (even 12.0 possible)
Most info on the chart.
Trade carefully!
Trade closed: stop reached
Entry was too early. Big push after
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.